277 related articles for article (PubMed ID: 6602726)
1. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease.
Niemelä O; Risteli L; Sotaniemi EA; Risteli J
Gastroenterology; 1983 Aug; 85(2):254-9. PubMed ID: 6602726
[TBL] [Abstract][Full Text] [Related]
2. [Serum aminoterminal type III procollagen peptide level and killer cell activity in patients with alcoholic liver diseases].
Schnabel R; Jaszovszky S; Bokor M; Garam T
Orv Hetil; 1991 Jul; 132(27):1479-83. PubMed ID: 1956678
[TBL] [Abstract][Full Text] [Related]
3. [The procollagen-III peptide in the clinical surveillance of alcoholic hepatopathy and other chronic hepatopathies].
Pagani A; Pranzo A; Sala N; Galante T
Recenti Prog Med; 1994 Sep; 85(9):425-8. PubMed ID: 7938873
[TBL] [Abstract][Full Text] [Related]
4. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis.
Li J; Rosman AS; Leo MA; Nagai Y; Lieber CS
Hepatology; 1994 Jun; 19(6):1418-23. PubMed ID: 8188171
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of serum procollagen peptide measurements in alcoholic liver disease.
Savolainen ER; Goldberg B; Leo MA; Velez M; Lieber CS
Alcohol Clin Exp Res; 1984; 8(4):384-9. PubMed ID: 6385761
[TBL] [Abstract][Full Text] [Related]
6. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
7. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
[TBL] [Abstract][Full Text] [Related]
8. [Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].
Pagani A; Zigliani P; Pranzo A; Galante T
Minerva Med; 1992 Nov; 83(11):715-20. PubMed ID: 1461542
[TBL] [Abstract][Full Text] [Related]
9. [Serum determination of N-terminal peptide of type III procollagen as a marker of fibrotic activity].
García Montes JM; De Bonilla Blánez F; Herrerías Gutiérrez JM
Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):241-5. PubMed ID: 2734469
[TBL] [Abstract][Full Text] [Related]
10. Determination of the aminoterminal peptide of procollagen type III and laminin P1 in serum of patients with chronic liver disease.
Kárteszi M; Szalay L; Cornides A; Dávid K; Fehér J
Acta Med Hung; 1988; 45(3-4):277-86. PubMed ID: 3249655
[TBL] [Abstract][Full Text] [Related]
11. Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatitis and in cirrhosis of the liver and their diagnostic value.
Raedsch R; Stiehl A; Waldherr R; Mall G; Gmelin K; Götz R; Walker S; Czygan P; Kommerell B
Z Gastroenterol; 1982 Dec; 20(12):738-43. PubMed ID: 7164528
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M
Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314
[TBL] [Abstract][Full Text] [Related]
13. Procollagen-type III peptide serum concentrations in alcoholic and non-alcoholic liver disease.
Monarca A; Petrini C; Perolini S; Pozzi F; Adelasco L; Natangelo R; Croce G
Ric Clin Lab; 1985; 15(2):167-71. PubMed ID: 4059796
[TBL] [Abstract][Full Text] [Related]
14. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
Lieber CS; Weiss DG; Paronetto F;
Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
[TBL] [Abstract][Full Text] [Related]
15. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics.
Zachariae H; Søgaard H; Heickendorff L
Acta Derm Venereol; 1989; 69(3):241-4. PubMed ID: 2566230
[TBL] [Abstract][Full Text] [Related]
16. Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease.
Nouchi T; Worner TM; Sato S; Lieber CS
Alcohol Clin Exp Res; 1987 Jun; 11(3):287-91. PubMed ID: 3307495
[TBL] [Abstract][Full Text] [Related]
17. Procollagen III peptide levels in alcoholic liver disease and primary biliary cirrhosis.
van Zanten RA; van Leeuwen RE; Beukers R; Wilson JH
Neth J Med; 1988 Jun; 32(5-6):278-84. PubMed ID: 3393256
[No Abstract] [Full Text] [Related]
18. Procollagen-III peptide and chronic viral C hepatitis.
Jeffers LJ; Coelho-Little ME; Cheinquer H; Vargas C; Civantos F; Alvarez L; Reddy KR; Parker T; de Medina M; Li X
Am J Gastroenterol; 1995 Sep; 90(9):1437-40. PubMed ID: 7661165
[TBL] [Abstract][Full Text] [Related]
19. Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C.
Luo JC; Hwang SJ; Chang FY; Chu CW; Lai CR; Wang YJ; Lee PC; Tsay SH; Lee SD
Hepatogastroenterology; 2002; 49(44):478-81. PubMed ID: 11995477
[TBL] [Abstract][Full Text] [Related]
20. Effect of an intravenous infusion of ethanol on serum enzymes and lipids in patients with alcoholic liver disease.
Nishimura M; Hasumura Y; Takeuchi J
Gastroenterology; 1980 Apr; 78(4):691-5. PubMed ID: 7353755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
